Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma
Clinical trial NCT00635323 · COMPLETED
Trial details
- NCT number
- NCT00635323
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.